HemaCare Corporation

HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy. It offers human blood cellular components derived from peripheral blood, bone marrow, disease-state biospecimens, and cord blood. In addition, the company offers donor recruitment, tissue collection, cell isolation and processing, packaging and shipping, and consulting services. Its network of FDA-registered, GMP/GTP-compliant collection centers ensures donor materials available to customers, as well as for use within its isolation laboratory. The company has strategic partnership with Charles River Laboratories International Inc. for human immune system research. HemaCare Corporation was founded in 1978 and is headquartered in Northridge, California. As of January 3, 2020, HemaCare Corporation operates as a subsidiary of Charles River Laboratories International, Inc.